Healthcare Innovation November 7, 2025
CFO Celeste Mellet said the insurer is “not seeing anything” suggesting medical and pharmacy cost growth will slow in the coming year
There won’t be too much of a good thing at Humana Inc. in 2026.
Speaking to analysts and investors on Nov. 5 after the Louisville-based insurer and healthcare services provider reported its third-quarter results, President and CEO Jim Rechtin said his team is prepared to tap the brakes on Medicare sales during the current annual enrollment period. Outlining Humana’s focus on customers’ lifetime value over simply pumping enrollment numbers, Rechtin said he’s also adamant that Humana’s operations not be stretched by the addition of new plan members.
“We will take as much growth as possible from improved retention....







